Search for: "ACTAVIS"
Results 821 - 840
of 1,006
Sorted by Relevance
|
Sort by Date
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge (Patent Docs) Kaletra… [read post]
4 Feb 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
6 Apr 2018, 3:42 am
Interestingly, in light of the Supreme Court decision in Actavis v Lilly having been handed down after the first instance judgment in the present proceedings, Regeneron appears to have argued that even if Kymab was right on construction, there was still infringement under the newly-conceived English law doctrine of equivalents. [read post]
10 Dec 2018, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
18 Nov 2019, 4:24 am
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
16 Dec 2009, 3:39 am
(Patent Docs) Nuvigil (Armodafinil) – US: Cephalon files patent infringement suit against Actavis following Para IV challenge (Patent Docs) (GenericsWeb) Thrombin(Coagulation factor II) - US: Court denies King Pharmaceuticals’ injunction motions against ZymoGenetics in trademark suit: King Pharmaceuticals, Inc. v. [read post]
18 Feb 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
22 Jul 2014, 10:17 am
While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older,… [read post]
11 Jan 2011, 11:07 pm
Senators follow House colleagues in making BPCIA exclusivity clarifications; New study suggests benefits of longer drug exclusivity period (FDA Law Blog) US: BPCIA’s principal authors seek to clarify Congressional intent with respect to 12-year exclusivity period; PhRMA/BIO request ‘umbrella exclusivity’ (FDA Law Blog) US: BIO’s IP priorities for 2011 (PatentlyBIOtech) US: BIO survey shows support for DNA-based patents despite some reservations (Patent Docs) US:… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
14 Jan 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
17 Feb 2010, 2:02 pm
This particular Kat was busy digesting the Court of Appeal's decision in Actavis v Novartis when another part of the IPKat commented on it here. [read post]
4 Mar 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
26 Nov 2018, 2:09 am
In addition, although the question answered by the CJEU dealt with article 3 (a), its legal grounds may also be applied to interpret article 3 (c), as shown by the judgment of 12 March 2015 (Case C-577/13 Actavis v. [read post]
16 Nov 2010, 5:16 pm
Actavis, 593 F.3d 428, 449 (5th Cir. 2010); Mensing v. [read post]
21 Mar 2012, 11:32 am
.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
30 Nov 2017, 8:59 pm
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
6 Dec 2018, 1:00 pm
Actavis, 570 U.S. 136 (2013), parties entering into trademark settlements are not immune from antitrust liability. [read post]
